By Pamela McLoughlin, Hartford Courant (TNS)

HARTFORD, Conn. — About 170,000 women in the United States are living with metastatic breast cancer — or cancer that has spread to other organs — and eventually leads to death.

Now, a team led in part by oncologists from the Yale cancer hospital is looking to drastically change that outcome through new clinical trials that will begin in April and are funded for six years.

Dr. Eric Winer, director of Yale Cancer Center and an oncologist specializing in breast treatment for 35 years, said he’s “totally excited” about this, one of the more innovative studies.

He said the trials are looking for “best new therapies for people with metastatic breast cancer to really try to make significant headway.”

“We desperately need to make progress,” Winer s

See Full Page